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Shen et al. show that genome-derived
DNA is present in the cytosol of many
mouse and human tumor cells. Cloning of
cytosolic DNA suggests that cytosolic
DNA has the potential to form non-B DNA
structures and frequently contains
retroelements. Cytosolic DNA also
contributes to type I IFN-dependent
rejection of lymphoma cells.
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The DNA damage response (DDR) induces the
expression of type I interferons (IFNs), but the under-
lying mechanisms are poorly understood. Here, we
show the presence of cytosolic DNA in different
mouse and human tumor cells. Treatment of cells
with genotoxic agents increased the levels of cyto-
solic DNA in a DDR-dependent manner. Cloning of
cytosolic DNA molecules from mouse lymphoma
cells suggests that cytosolic DNA is derived from
unique genomic loci and has the potential to form
non-B DNA structures, including R-loops. Overex-
pression of Rnaseh1, which resolves R-loops,
reduced the levels of cytosolic DNA, type I Ifn tran-
scripts, and type I IFN-dependent rejection of lym-
phoma cells. Live-cell imaging showed a dynamic
contact of cytosolic DNA with mitochondria, an
important organelle for innate immune recognition
of cytosolic nucleotides. In summary, we found that
cytosolic DNA is present in many tumor cells and
contributes to the immunogenicity of tumor cells.
INTRODUCTION
The genomic DNA of cells is constantly challenged by exoge-
nous and endogenous DNA-damaging events (Hakem, 2008).
Double-stranded DNA (dsDNA) breaks can occur as often as
50 times per cell cycle in human cells (Vilenchik and Knudson,
2003). Cells protect their genome integrity by activating the
DNA damage response (DDR), which counteracts the adverse
consequences of DNA lesions by inducing repair of damaged
DNA or apoptosis (Burhans and Weinberger, 2007).
DNA breaks caused by endogenous cellular processes are
often associated with stalled or collapsed replication forks
(Branzei and Foiani, 2010). The progression of replication forks460 Cell Reports 11, 460–473, April 21, 2015 ª2015 The Authorscan be blocked by a variety of obstacles, including DNA-binding
proteins, highly transcribed DNA sequences, unusual DNA
structures, common fragile sites (CFSs), repetitive sequences,
and RNA:DNA hybrids (R-loops) (Wang and Vasquez, 2004).
Deficiencies in Rnaseh1 or Rnaseh2, two ribonucleases that
hydrolyze the RNA strand from RNA:DNA hybrids, lead to
increased genomic instability by stalling replication forks (Agui-
lera and Garcı´a-Muse, 2012). Stalled replication forks are re-
paired by homologous recombination (HR), which is generally
non-mutagenic but can lead to amplification or deletion of re-
petitive DNA elements.
Recognition of nucleotides by Toll-like receptors (TLRs) and
cytosolic nucleic acid sensors activates NF-kB, interferon regu-
lator factor (IRF) 3, and IRF7 to produce type I interferons (IFNs)
and other pro-inflammatory cytokines (Yanai et al., 2009). Type I
IFNs induce the transcription of many anti-viral genes and acti-
vate important components of the innate and adaptive immune
system, including natural killer (NK) cells, T cells, and B cells.
NF-kB and IRF3 also are activated in response to DNA damage,
and activation of the DDR induces the expression of type I IFNs
(Brzostek-Racine et al., 2011; Lam et al., 2014). However, the
mechanisms leading to the expression of type I IFNs in response
to DNA damage have not been well characterized.
Here we report the constitutive presence of cytosolic single-
stranded DNA (ssDNA) and dsDNA in several tumor cell lines.
Treatment of tumor cells with genotoxic replication inhibitors
increased the levels of DNA in the cytosol of tumor cells.
Cloning and analysis of cytosolic DNA present in mouse lym-
phoma cells showed that cytosolic DNA is derived from both
intragenic and intergenic regions of genomic DNA. Cytosolic
DNA clones often contained different classes of retroelements
and sequences with the potential to form non-B DNA structures
including R-loops. Overexpression of Rnaseh1, which degrades
R-loops, decreased the levels of cytosolic DNA, type I IFNs, and
type I IFN-dependent rejection of tumor cells. Cytosolic DNA
was found to be in close association with mitochondria, an
important organelle for innate immune recognition of cytosolic
nucleic acids. In summary, our data suggest that the presence
Figure 1. Presence of Cytosolic DNA in Hu-
man and Mouse Tumor Cells
(A) Mouse B cell lymphoma BC2 cells were treated
with DMSO (upper row) or 10 mMAra-C (lower row)
for 16 hr and co-stained for the mitochondrial
marker COX IV (green) and ssDNA (left) or dsDNA
(right) (red) in the presence of DAPI (blue).
(B) Murine fibroblasts derived from C57BL/6 mice
were treated with DMSO or 10 mM Ara-C for 16 hr
and stained with ssDNA- (left) or dsDNA-specific
(right) antibodies (red) and DAPI (blue).
(C) B220+ (green) B cell lymphomas arising in
Em-Mycmice were stained for cytosolic DNA using
ssDNA- (left) or dsDNA-specific (right) antibodies
(red) and DAPI (blue).
(D) Human lung carcinoma A549 cells (top) and
leukemic monocytic THP1 cells (bottom) were
stained for cytosolic ssDNA (left) or dsDNA (right,
red). Cells were co-stained for the mitochondrial
marker COX IV (green) and DAPI (blue). The z stack
images were acquired by confocal microscopy
and analyzed using Imaris to generate iso-surface
plots. Scale bars, 10 mm. Data are representative
of more than three independent stainings.of genome-derived DNA species in the cytosol of tumor cells
contributes to the immune rejection of tumor cells.
RESULTS
DNA Damage Induces the Presence of Cytosolic DNA in
Tumor Cell Lines
IRF3 is activated in response to recognition of viral or bacterial
nucleotides by innate receptors including TLRs andRIG-I-like re-
ceptors (RLRs) (Yanai et al., 2009). DNA damage also activates
IRF3 and induces the secretion of type I IFNs (Brzostek-Racine
et al., 2011; Lam et al., 2014). We previously found that DNA is
present in the cytosol of the mouse B-cell lymphoma cell line
BC2, a B cell lymphoma cell line derived from Em-Mycmice, afterCell Reports 11, 460–treatment with the genotoxic replication
inhibitor cytosine b-D-arabinofuranoside
hydrochloride (Ara-C) (Figure 1A; Lam
et al., 2014).
To extend these initial studies, we
treated the human colon carcinoma cell
line HCT116 and the cervical cancer cell
line HeLa with aphidicolin, a genotoxic
drug that blocks DNA polymerases, but
does not affect the replication of mito-
chondrial DNA (Zimmermann et al.,
1980). To avoid potential staining of
RNA, cells were treated with RNase
before staining with the ssDNA- or
dsDNA-specific antibodies. Treatment of
BC2, HCT116, and HeLa cells with geno-
toxic agents increased the levels of cyto-
solic dsDNA (Figures 1A, S1A, and S1B;
Movie S1). The levels of ssDNA increased
in BC2 and HeLa cells, but not HCT116cells (Figures 1A, S1A, and S1B). Importantly, pretreatment of
cells with the ssDNA-specific S1 nuclease abrogated the ssDNA
staining, while DNase I abolished dsDNA staining, suggesting
that the antibodies used in this study specifically recognize
ssDNA or dsDNA (Figures S1C and S1D). Furthermore, all cells
tested negative for mycoplasma.
To investigate whether cytosolic DNA is specific for tumor
cells, murine fibroblasts were extracted from tails and ears of
C57BL/6 mice and stained for ssDNA and dsDNA. No DNA was
detected in the cytosol of primary fibroblasts (Figure 1B). Treat-
ment of fibroblasts with Ara-C induced low levels of dsDNA in
the cytosol, suggesting that cytosolic DNA is absent in
normal cells but appears in response to DNA damage (Fig-
ure 1B). To verify that cytosolic DNA is localized outside473, April 21, 2015 ª2015 The Authors 461
Figure 2. Partial Co-localization of Cytosolic DNA with LysoTracker Staining
(A–E) A549 cells were stained for ssDNA (left) or dsDNA (right, red) and the autophagy marker LC3 (A), the stress granule marker G3BP1 (B), the early endosomal
marker EEA1 (C), the lysosomal marker LAMP2 (D), and the late endosomal marker and lysosomal marker CD63 (E) (green) in the presence of DAPI (blue). Co-
localization scores (Rr) ±SD indicated in themerged pictures were calculated using Pearson’s coefficient equation; Rr = 1, perfect co-localization; Rr = 0, random
localization.
(legend continued on next page)
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mitochondria, cells were co-stained with the mitochondrial mar-
ker cytochrome coxidase subunit IV (COX IV). Three-dimensional
(3D) iso-surface rendering of confocal images showed that ama-
jority of the extranuclear DNA was present outside of mitochon-
dria (Figures 1, S1A, andS1B). In summary, our data demonstrate
that DNA-damaging agents increase the levels of extramitochon-
drial DNA in the cytosol of the tested tumor cell lines.
Constitutive Presence of DNA in the Cytosol of Several
Human Cell Lines
We previously found that ssDNA and dsDNA are constitutively
present in the cytosol of the mouse lymphoma cell line Yac-1
(Lam et al., 2014) and Em-Myc B cell lymphomas (Figures 1C
and S2A). To extend these observations to human cell lines,
we stained the human lung carcinoma cell line A549, the acute
monocytic leukemia cell line THP1, and the lung fibroblast cell
line MRC5 for the presence of cytosolic ssDNA and dsDNA (Fig-
ures 1D, S2B, and S2C). Similar to Yac-1 cells and Em-Myc lym-
phomas, ssDNA and dsDNA were constitutively present in the
cytosol of the tested human cell lines.
Partial Co-localization of Cytosolic DNA with Late
Endosome Marker CD63
To test if cytosolic DNA is localized to cellular organelles, we
stained A549 cells, which have a clearly visible cytoplasm, for
DNA and different organelles. Autophagy recently was found to
remove cytosolic pathogen-derived DNA (Liang et al., 2014).
However, only minimal co-localization of the autophagosome
marker LC3 with DNA was observed in A549 cells, indicating
that the majority of cytosolic DNA is not present in LC3-contain-
ing autophagosomes (Figure 2A).
Stress granules are enriched in factors involved inRNA turnover
and were found to contain the Z-DNA-binding protein (ZBP1), a
putative cytosolic DNA sensor (Ng et al., 2013). However, cyto-
solic DNA only marginally co-localized with Ras-GTPase-acti-
vating protein SH3 domain-binding protein 1 (G3BP1), which
contributes to the formation of stress granules (Figure 2B).
Mitochondria-derived DNA recently was shown to be
degraded by lysosomes (Fujiwara et al., 2013). To analyze
whether cytosolic DNA co-localizes with lysosomes, we stained
A549 cells for the early endosomal marker EEA1, the late endo-
some marker CD63, and the lysosome-associated membrane
protein-2 (LAMP2). Cytosolic DNA only minimally co-localized
with the EEA1 and LAMP2markers (Figures 2C and 2D). Interest-
ingly, a subset of cytosolic DNA partially co-localized with CD63
(Figure 2E). CD63 can recycle to the cell surface via the exocytic
pathway, indicating that some cytosolic DNAmight be secreted.
Live-cell imaging of A549 cells with the lysosome-specific vital
dye LysoTracker and the dsDNA-specific vital dye PicoGreen
supported the conclusion that cytosolic dsDNA largely resides
outside of lysosomes (Figure 2F; Movie S2). However, a subset
of DNA in the cytosol transiently co-localized with lysosomes.
Upon co-localization of cytosolic DNA with LysoTracker, the(F) Live-cell imaging of A549 cells stained with 3 ml/ml vital dsDNA-specific dye Pic
for 30 min. Cells were analyzed by confocal live-cell imaging using a frame-capt
numbers in the images. The white box indicates an example of co-localization of P
of two independent stainings.DNA staining disappeared, suggesting that some cytosolic
DNA is degraded in lysosomes (Figure 2F; Movie S2). In sum-
mary, our data demonstrate that the majority of cytosolic DNA
in tumor cells is present outside of mitochondria, autophago-
somes, stress granules, lysosomes, and early endosomes.
Cytosolic DNA Is Associated with Mitochondria
3D iso-surface rendering of MitoTracker and PicoGreen staining
indicated that cytosolic DNA was frequently present in close
proximity to mitochondria (Figures 1, S1, and S2). To better un-
derstand if cytosolic DNA is associated with mitochondria, we
analyzed the movement of cytosolic DNA and mitochondria in
A549 cells. Time-lapse analysis suggested that cytosolic dsDNA
is in close and dynamic contact with mitochondria (Figure 3A;
Movie S3). Similarly, staining of A549 cells with OliGreen, a vital
oligonucleotide- and ssDNA-specific dye, showed a close asso-
ciation of ssDNA with mitochondria in the cytosol of A549 cells
(Figure 3B; Movie S4). Treatment of HeLa cells with aphidicolin
induced the presence of cytosolic dsDNA (Movie S5) when
compared to DMSO-treated HeLa cells (Movie S6), some of
which was not associated with mitochondria (Figure 3C). The
free DNA was smaller in size and moved faster than mitochon-
dria-associated DNA. When HeLa cells were allowed to recover
from aphidicolin for 16 hr, the aphidicolin-induced cytosolic DNA
disappeared in most cells, suggesting that the turnover rate of
such DNA is less than 16 hr (Movie S7).
PicoGreen also stains mitochondrial DNA (Ashley et al., 2005).
Increasing the intensity of the PicoGreen signal revealed weaker
PicoGreen signals in the cytoplasm of A549 cells, which overlap-
ped with MitoTracker staining (Figure 3D). We previously found
that blocking of the DDR resulted in the disappearance of dsDNA
in the cytosol of Yac-1 cells (Lam et al., 2014). Similarly, inhibition
of the DDR-initiating kinases ATM and ATR in A549 cells abro-
gated the cytosolic dsDNA staining (Figure 3E). In contrast,
staining of mitochondrial dsDNA by PicoGreen was unchanged
by inhibition of the DDR (Figure 3E). Hence, PicoGreen stains
both cytosolic and mitochondrial dsDNA in A549 cells, but mito-
chondrial dsDNA staining is significantly weaker compared to
cytosolic dsDNA staining.
ATM and ATR are predominantly nuclear proteins and the
decrease of cytosolic DNA in cells treated with ATM and ATR in-
hibitor suggested that cytosolic DNA is derived from nuclear
DNA (Lam et al., 2014). Time-lapse imaging analysis further indi-
cated the release of DNA from the nucleus of A549 cells (Fig-
ure 3F). Similarly, PicoGreen staining of Ara-C-treated BC2 cells
showed nuclear DNA, which appeared to be released into the
cytosol (Figure S2D; Movie S1).
Cytosolic DNA Is Derived from Genomic DNA
To determine the origin of cytosolic dsDNA, we cloned cytosolic
dsDNA from primary Em-Myc B cell lymphomas and Ara-C-
treated BC2 cells. We were not able to clone dsDNA from Yac-
1 cells. DNA in cytosolic fractions showed a length distributionoGreen (green) for 1 hr and 50 nM lysosome-specific vital dye LysoTracker (red)
ure rate of 9 s. Chronological order of images taken every 27 s is indicated by
icoGreen and LysoTracker staining. Scale bars, 10 mm. Data are representative
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Figure 3. Cytosolic DNA Is Partially Associated with Mitochondria
(A) Live-cell imaging of A549 cells stained with 3 ml/ml PicoGreen (green) for 1 hr and 100 nM mitochondria-specific vital dye MitoTracker (red) for 30 min. Cells
were analyzed by confocal live-cell imaging using a frame-capture rate of 9 s. Chronological order of images taken every 27 s is indicated by numbers in the
images.
(B) A549 cells were stained with 3 ml/ml vital ssDNA-specific dye OliGreen (green), 100 nMMitoTracker (red), and 1 mg/ml Hoechst dye (blue) for 1 hr. Staining was
analyzed as outlined in (A).
(legend continued on next page)
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Figure 4. Cloning of Cytosolic DNA Present
in Lymphoma Cells
(A) 0.5 mg 1-kb DNA ladder (lane 1), 0.5 mg 0.1-kb
DNA ladder (lane 2), 9 mg (lane 3), and 5.5 mg
(lane 4) of independently purified cytosolic frac-
tions of BC2 cells treated with 10 mM Ara-C for
16 hr were electrophoresed and stained using
SYBR Safe DNA gel stain.
(B) Numbers of dsDNA (left) and ssDNA (right)
sequences cloned from tumor cells derived from
Em-Myc mice (white columns), Yac-1 cells (gray
columns), and BC2 cells treated with 10 mM Ara-C
for 16 hr (black columns) with the indicated number
of bp are shown.
(C) Frequencies of dsDNA and ssDNA clones
derived from Em-Myc tumor cells, Ara-C-treated
BC2 cells, and Yac-1 cells localizing to intragenic
and intergenic regions of the mouse genome are
shown. Nd, not determined.
(D) Frequencies of the indicated retroelements in
the mouse genome (left column), dsDNA clones
derived from Em-Myc tumors (middle column), and
dsDNA clones of BC2 cells treated with 10 mM
Ara-C for 16 hr (right column) are shown. Fold
enrichment over average percentage of retroele-
ments in mouse genome (numbers in left column)
are indicated according to the color scale below
the table for clones derived from Em-Myc tumors
(middle column) and BC2 cells (right column).
(E) Frequencies of dsDNA and ssDNA clones with
non-B DNA motifs and triplex DNA-forming po-
tential within the cloned DNA or within 500 bp of
the surrounding genomic loci were determined
using online databases. Nd, not determined.
(F) A representative sequenced dsDNA clone pu-
rified from the cytosolic fraction of Ara-C-treated
BC2 cells (bold letters) is shown in the genomic
context. The predicted triplex sequence according
to the triplex search tool is shown in red letters and
putative triplex DNA structures are indicated below
the sequence.
(G) B220+ (green) B cell lymphomas arising in
Em-Myc mice were stained for RNA:DNA hybrids
using the RNA:DNA-specific antibody S9.6 (red) in
the presence of DAPI. The z stack images were
acquired by confocal microscopy and analyzed
using Imaris to generate iso-surface plots. Scale
bar, 5 mm.consistent with DNAwrapped around nucleosome core particles
(Figure 4A). Large genomic DNA fragments were not detected by
gel electrophoresis of cytosolic DNA fractions. Furthermore, fail-
ure to amplify genomic loci by PCR using primers specific for two(C) Live-cell imaging of HeLa cells treated with DMSO (top row) or 4 mM aphidic
cultured for 16 hr before analysis (bottom row). Cells were analyzed as outlined
(D) PicoGreen staining of the first image shown in (A) was enhanced using Photosh
of mitochondrial DNA.
(E) A549 cells were treated with 10 mMATM-specific inhibitor KU60019 and the AT
of treatment, cells were incubated with 3 ml/ml PicoGreen (green). Then, 100 nM o
analysis. White arrows indicate cytosolic DNA. MitoTracker staining was remove
(F) Live-cell imaging of A549 cells stained with 3 ml/ml PicoGreen (green) for 1 hr. A5
of 30 s. White boxes indicate nuclear DNA that moves to the cytosol. Cells were
and E). Data are representative of more than three independent stainings.different loci of the C57BL/6 mouse genome suggested that the
purified fractions were largely free of genomic DNA (Figure S3). A
total of 231 dsDNA sequences were cloned from Ara-C-treated
BC2 cells and tumor cells present in Em-Myc mice (Figure 4B).olin (middle row) for 16 hr. Some aphidicolin-treated cells were washed and
in (A).
op. MitoTracker staining was removed in the right image for better visualization
R-specific inhibitor VE-821 (bottom) or DMSO (top) for 3 hr. During the last hour
f the mitochondria-specific vital dyeMitoTracker (red) was added 30min before
d in the right image for better visualization of mitochondrial DNA.
49 cells were analyzed by confocal live-cell imaging using a frame-capture rate
analyzed by confocal microscopy. Scale bars, 2 mm (A and D) and 5 mm (B, C,
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The length of the cloned sequences varied from 18 to 1,128 bp
(Figure 4B). Comparison of the cloned DNA sequences to the
mouse genome database showed that 98.2% of the clones
from tumors of Em-Myc mice and all the clones from Ara-C-
treated BC2 cells were derived from unique loci on the mouse
genome; and 34% of the clones from tumors of Em-Myc mice
and 44% of the clones derived from BC2 cells contained point
mutations compared to the sequences in the mouse genome
database, but the sequence misalignments were <4% of the
cloned sequence. Also, 48.21% of sequences from tumors of
Em-Myc mice and 48.57% of dsDNA sequences cloned from
Ara-C-treated BC2 cells localized to intragenic genomic se-
quences (Figure 4C).
To characterize the origin and nature of cytosolic ssDNA, we
adopted a cloning method for ssDNA described previously
(Stetson et al., 2008). We cloned 24 different ssDNA sequences
from Ara-C-treated BC2 and Yac-1 cells, but were unable to
clone ssDNA from tumors of Em-Myc mice (Figure 4B). In
contrast to dsDNA clones, ssDNA sequences were shorter,
ranging from 14 to 59 bp (Figure 4B). Of ssDNA clones, 88.8%
from Ara-C-treated BC2 cells and 57.1% from Yac-1 cells
matched unique mouse genome loci. The remaining ssDNA se-
quences aligned with several sequences in the mouse genome.
Also, 11.1% of ssDNA clones from Ara-C-treated BC2 cells
were intragenic, while 33.3% of ssDNA clones from Yac-1 cells
located to intragenic regions (Figure 4C). In summary, our data
indicate that at least a fraction of cytosolic DNA is derived
from intergenic and intragenic genomic DNA loci in the tested
lymphoma cells.
Cloned Cytosolic DNA Contains Retroelements and
Potentially Forms Non-B DNA Structures
RepeatMasker is a program that screens DNA sequences for
interspersed repeats and low-complexity elements (Tarailo-
Graovac and Chen, 2009). Analysis of the cloned sequences
using RepeatMasker showed that 58.9% of dsDNA clones
from tumor cells of Em-Myc mice and 35.7% of dsDNA clones
from Ara-C-treated BC2 cells contained retroelements, while
the average retroelement distribution is 41.2% in the mouse
genome (Figure 4D; Waterston et al., 2002). Analysis of the
cloned dsDNA sequences showed the presence of most major
classes of retrotransposons, namely, short interspersed nuclear
elements (SINEs), long interspersed nuclear elements (LINEs),
and long terminal repeats (LTRs), in many of the cytosolic dsDNA
clones, although none of the clones contained functional retro-
elements (Figure 4D). Satellites, small RNA, and ERV class III,
were enriched in clones derived from tumors present in Em-
Myc mice, while Line L3 and to a lesser degree ERV class I,
TcMar-Tigger, and satellites were more abundant within the
cloned sequences from Ara-C-treated BC2 cells. In contrast,
no SINE ID, SINE MIR, LINE2, L3 ERV class I, and DNA elements
were found in clones derived from Em-Myc mice. Small RNA se-
quences, LINE2, simple repeats, and ERV class III elements were
underrepresented in dsDNA clones derived from Ara-C-treated
BC2 cells. No retroelements, interspersed repeats, or low-
complexity elements were found in the ssDNA clones derived
from BC2 cells or Yac-1 cells, possibly due to their short size.
The changes in the presence of retroelements compared to their466 Cell Reports 11, 460–473, April 21, 2015 ª2015 The Authorsaverage presence in the mouse genome further support the
conclusion that the cytosolic fractions used for cloning did not
contain significant amounts of genomic DNA fragments.
To test whether the cloned DNA sequences have the potential
to form non-canonical DNA structures, we analyzed the se-
quences for thepresenceof non-BDNAmotifs usingdifferent pre-
diction algorithms. Non-B DNA structures include G-quadruplex,
Z-DNA, cruciforms, triplex, and different types of repeats (Zhao
et al., 2010). Analysis of cytosolic dsDNA sequences from Em-
Myc tumors revealed that 32.2% of the clones contained DNA
stretches predicted to form non-B DNA structures (Figure 4E).
98.2% of clones contained potential non-B DNA structures
when500bparound thegenomiccloned lociwere included, since
non-B DNA structures might have been lost during the cloning
procedure. Similarly, 60% of sequences cloned from Ara-C-
treated BC2 cells contained predicted non-B DNA structures,
while 98.9% of clones comprised such structures when 500 bp
around the cloned genomic loci were considered. For ssDNA
clones, non-B DNA-forming sequences were found within
500 bp of all ssDNA clones derived from Yac-1 cells and Ara-C-
treated BC2 cells, but not within the cloned sequences. Further
analysisof the non-BDNAstructures indicated thepresenceof tri-
ple-stranded DNA-forming stretches in 5.36% of clones from tu-
mors of Em-Myc mice and 29% of sequences when 500 bp of
the surrounding genomic loci were included in the analysis (Fig-
ures 4E and 4F). In clones derived from Ara-C-treated BC2 cells,
16% of sequences were predicted to form triple-stranded DNA
and 52% of clones when 500 bp around the genomic loci of the
clones were considered (Figures 4E and 4F). Some genomic
DNA stretches can fold into intramolecular triple-stranded DNA
structures (Wongsurawat et al., 2012). Alternatively, triple-
stranded DNA can occur when nascent RNA transcript and DNA
template form RNA:DNA hybrids and leave the non-transcribed
DNA strand unpaired. Staining of the tumor cells derived from
Em-Myc mice using RNA:DNA hybrid-specific S9.6 antibodies
supported the conclusion that triple-stranded DNA was present
in the cytosol of tumor cells (Figure 4G; Boguslawski et al., 1986).
To confirm the cytosolic nature of the cloned DNA, we chose
two >700-bp clones derived from Ara-C-treated BC2 cells as
probes in a modified fluorescence in situ hybridization (FISH)
assay. Probe 1 contained an LTR (ERVL-MaLRs) and a hAT-
Charlie element. Probe 2 contained a LINE1 retroelement,
although the elements appeared to be non-functional. FISH anal-
ysis of untreated BC2 cells using the two biotinylated probes de-
tected two signals for each probe in the nucleus (Figure 5A).
Interestingly, we also detected a weak cytosolic signal when
using probe 2. These data support the conclusion that the se-
quences used as probe 1 and 2 are derived from unique genomic
loci on homologous chromosomes in BC2 cells. Upon treatment
of BC2 cells with Ara-C, the probe detected corresponding se-
quences in the cytosol and in the nucleus of BC2 cells (Figure 5A).
Several areas of hybridization were observed in the Ara-C-
treated BC2 cells, indicating that the sequences were amplified
in response to Ara-C treatment. FISH analysis of Yac-1 cells us-
ing probes 1 and 2, which were cloned from Ara-C-treated BC2
cells, detected hybridization signals in the nucleus, but not in the
cytosol (Figure 5B). Interestingly, several hybridization signals
were detected in Yac-1 cells by probe 1, but not probe 2,
Figure 5. FISH with Cloned DNA Probes Detects Cytosolic DNA in
Ara-C-Treated BC2 Cells
(A) FISH of BC2 cells treated with DMSO (first and second rows) or Ara-C (third
and fourth rows) using the biotin-labeled DNA probe 1 (red, first and third rows)
or the probe 2 (red, second and fourth rows) cloned from Ara-C-treated BC2
cells in the presence of DAPI (blue). As a control, a Gfp-specific probe was
used for hybridization (third column).
(B) Yac-1 cells were hybridized using the probes 1 and 2 cloned from Ara-C-
treated BC2 cells as described in (A). As a control, Yac-1 cells were stained
with a Gfp-specific probe. White arrows indicate cytosolic FISH signals. Nd,
not determined. Scale bars, 5 mm.suggesting that the corresponding genomic sequence was
amplified in Yac-1 cells. In summary, our data suggest that
genomic loci with the potential to form triplex DNA structures
give rise to cytosolic DNA in tumor cells. The results further indi-
cate that cytosolic DNA might be derived from alternative
genomic loci in different tumor cells.Overexpression of Rnaseh1 and Trex1 Reduces the
Levels of Cytosolic DNA in Tumor Cells
Triple-stranded DNA (R-loops) causes genomic DNA breaks
(Helmrich et al., 2011), while RNASE H1 suppresses DNA dam-
age by hydrolyzing RNA from RNA:DNA hybrids (Wahba et al.,
2011). Consistent with this possibility, overexpression of
Rnaseh1 in BC2 cells reduced the phosphorylation of the DNA
damage marker H2AX and the DDR marker p53 (Figures S4A
and S4B). The levels of cytosolic ssDNA and dsDNA were
decreased in Rnaseh1-overexpressing BC2 cells in response
to Ara-C compared to control plasmid-transduced BC2 cells
(Figure 6A). Overexpression of Rnaseh1 also reduced the levels
of cytosolic ssDNA and dsDNA in Yac-1 (Figure 6B) and EmM1
cells (Figure 6C) compared to control cells. Only amodest reduc-
tion of Rnaseh1 transcript levels was achieved by different
Rnaseh1-specific small hairpin RNAs (shRNAs), which had no
effect on the levels of cytosolic ssDNA or dsDNA (Figures
S4C–S4F). Rnaseh1was shown to play an essential role in main-
taining cell survival and proliferation, which may explain the inef-
ficient inhibition of Rnaseh1 expression by the different tested
shRNAs (Cerritelli et al., 2003). To address the effects ofRnaseh1
deficiency on the presence of cytosolic DNA, we transfected
HCT116 and HeLa cells with Rnaseh1-specific small interfering
RNAs (siRNAs). Transient reduction of Rnaseh1 expression by
siRNA increased the levels of cytosolic DNA in A549 and HeLa
cells (Figure S5A), consistent with the conclusion that RNASEH1
counters DNA damage leading to the presence of cytosolic DNA.
The three prime repair exonuclease 1 (Trex1) is a 30-50 DNA
exonuclease with a preference for ssDNA and mispaired 30
termini (Yang et al., 2007). The ssDNA derived from endogenous
retroelements or aberrant reverse-transcription intermediates
were found to accumulate in Trex1-deficient cells (Stetson
et al., 2008). Overexpression of Trex1 abrogated ssDNA staining
in Ara-C-treated BC2 cells (Figures 6A and S5B). No effect of
Trex1 overexpression was observed on dsDNA levels in the
cytosol, indicating that dsDNA levels in Ara-C-treated BC2 cells
are independent of cytosolic ssDNA (Figure 6A). Similarly, over-
expression of TREX1 led to a significant decrease of cytosolic
ssDNA in HeLa cells (Figures S5C and S5D). We were not able
to study the effects of Trex1 in Yac-1 cells as overexpression
of Trex1 induced cell death (data not shown). Impaired expres-
sion of TREX1 by shRNA significantly increased the levels of
cytosolic ssDNA in TREX1 shRNA-transduced HeLa cells
compared to GIPZ non-silencing control transduced cells (Fig-
ures S5E and S5F). All tested mouse Trex1-specific shRNAs
failed to achieve a significant knockdown of Trex1 transcripts
(data not shown). We also could not investigate potential links
between cytosolic dsDNA and ssDNA as the overexpression of
a cytosolic Dnase1 induced apoptosis of BC2 cells and Yac-1
cells (data not shown). In summary, our data suggest that
Rnaseh1 suppresses the presence of cytosolic ssDNA and
dsDNA in tumor cells, while TREX1 degrades cytosolic ssDNA.
Overexpression of Rnaseh1 Reduces Type I IFNs
Expression and Type I IFN-Mediated Rejection of EmM1
Cells
Recognition of cytosolic DNA by nucleic acid sensors induces
the expression of type I IFNs (Yanai et al., 2009). TransfectionCell Reports 11, 460–473, April 21, 2015 ª2015 The Authors 467
Figure 6. Overexpression of Rnaseh1 Reduces the Presence of Cytosolic ssDNA and dsDNA
(A) BC2 cells were transduced with a retroviral vector encodingGfp (Ctrl),Rnaseh1-IRES-Gfp, or Trex1-IRES-Gfp. 5 days after transduction, GFP+ BC2 cells were
treated with DMSO or 10 mM Ara-C for 16 hr and analyzed for the presence of cytosolic ssDNA or dsDNA (red) in the presence of DAPI (blue). DAPI staining was
removed in some pictures for better visualization of the DNA staining. Quantification of the average intensity of ssDNA or dsDNA staining in DMSO-treated (white
bar) and Ara-C-treated (gray bar) BC2 cells is shown on the right.
(legend continued on next page)
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of primary murine fibroblasts with ssDNA and dsDNA clones
derived from Ara-C-treated BC2 cells induced the secretion of
IFN-b in fibroblasts (Figure S6A). Similarly, transfection of fibro-
blasts with cloned dsDNA fragments predicted to form triple-
stranded DNA induced the expression of IFN-b, but RNA:DNA
hybrids of the same sequences failed to induce IFN-b (Fig-
ure S6B), suggesting that ssDNA and dsDNA, but not RNA:DNA
hybrids, are recognized by nucleic-acid-sensing pathways in fi-
broblasts. In accordance, overexpression of Rnaseh1 or Trex1
impaired the upregulation of Ifna4 and Ifnb transcript levels in
Ara-C-treated BC2 cells and reduced the constitutive transcript
levels in Yac-1 cells compared to control plasmid-transduced
cells (Figures 7A and 7B). Similarly, overexpression of Rnaseh1
in EmM1 cells led to a significant reduction of IFN-b protein level
in the supernatant (Figures 7C and S6C), while overexpression of
TREX1 reduced IFNA4 and IFNB transcript levels in HeLa cells
(Figure S6D). In contrast, IFNA4 and IFNB levels were increased
in TREX1 shRNA-transducedHeLa cells (Figure S6E). Hence, our
data suggest that the cytosolic ssDNA and dsDNA are recog-
nized by DNA sensors and induce the expression of type I IFNs
in tumor cells.
To test if type I IFNs contribute to the short-term rejection of
tumor cells, groups of five C57BL/6 mice were inoculated intra-
venously (i.v.) with syngeneic GFP+ EmM1. Injection of IFN (alpha
and beta) receptor 1 (IFNAR1)-blocking antibodies before tumor
cell inoculation increased the tumor load of GFP+ EmM1 cells in
the bone marrow and spleen (Figure 7D). To examine the role
of Rnaseh1 in type I IFN-mediated tumor rejection, we injected
i.v. equivalent numbers of differentially labeled Rnaseh1-Gfp
and Gfp-transduced EmM1 cells into C57BL/6 mice that were
administered IFNAR1-blocking or isotype control antibodies.
The labeled control and Rnaseh1-expressing EmM1 cells had
similar proliferation and apoptosis kinetics in vitro, resulting in
a constant ratio of the two cell populations in culture, which
was not changed by the presence of blocking IFNAR1 antibodies
(Figures S6F and S6G). In agreement with this observation, equal
numbers of Rnaseh1-Gfp and Gfp-transduced EmM1 cells were
present in the bone marrow of mice that received blocking
IFNAR1 antibodies (Figure 7E). In contrast, an 11-fold increase
of Rnaseh1-Gfp-transduced EmM1 cells over Gfp-transduced
EmM1 cells was observed in the bone marrow of isotype anti-
body-injected C57BL/6 mice, suggesting that RNASEH1 re-
duces type I IFN-dependent immune recognition of EmM1 cells
(Figure 7E).
NK cells were shown to play an important role in the rejection
of several experimental murine tumors (Vivier et al., 2011). To
address the role of NK cells in the rejection of EmM1 tumor cells,
we injected i.v. equivalent numbers of differentially labeled
Rnaseh1-Gfp and Gfp-transduced EmM1 cells into C57BL/6
mice that were administered NK cell-depleting or isotype control(B) Yac-1 cells were transduced with a retroviral vector encoding Gfp (Ctrl) or Rna
ssDNA or dsDNA (red) as outlined in (A). Quantification of the average intensity of s
Gfp-transduced (gray bar) Yac-1 cells is shown on the right.
(C) EmM1 cells were transduced with a retroviral vector encoding Gfp (Ctrl) or Rna
ssDNA or dsDNA (red) as outlined in (A). Quantification of the average intensity
transduced (gray bar) EmM1 cells is shown on the right. Only cytoplasmic regions
of the slide. *p < 0.05, **p < 0.01. Scale bars, 10 mm. Error bars indicate ± SD.antibodies (Figure S6H). Depletion of NK cells increased the per-
centage of Gfp (3.3-fold) and to a lesser degree Rnaseh1-Gfp-
transduced (2.3-fold) EmM1 cells in the spleen, suggesting that
NK cells recognition of EmM1 cells partially depends on cytosolic
DNA (Figure 7F). In contrast, depletion of NK cells had no impact
on the percentage of Rnaseh1-Gfp and Gfp-transduced EmM1
cells in the bone marrow, possibly due to the lower number of
mature NK cells or impaired depletion of NK cells in the bone
marrow (Figure 7F).
DISCUSSION
Herewe show that treatment of tumor cells with inhibitors of DNA
replication fork progression increases the presence of cytosolic
DNA in tumor cells with low levels of DNA in the cytosol. Replica-
tion forks often stall and collapse at specific genomic regions,
such as highly transcribed gene clusters, especially those that
are enriched in repetitive elements (Negrini et al., 2010). Repeti-
tive DNA can undergo structural changes leading to the forma-
tion of non-canonical DNA structures, such as cruciforms, triplex
DNA, Z-DNA, and G-quadruplex, which can impair the progress
of replication forks. Consistent with the conclusion that cytosolic
DNA is at least partially derived from replication-stress-associ-
ated gene clusters, cytosol-derived DNA often contained retro-
elements, some of which were located in introns of potentially
transcribed genes. Furthermore, in silico analysis using two
different DNA structure prediction programs suggested that
cytosolic DNA is derived from genomic regions, which contain
or are close to sequences with the potential to form non-B
DNA structures, such as triple-stranded DNA structures
(R-loops). R-loops can occur when nascent RNA transcripts
form stable RNA:DNA hybrids leaving the non-transcribed DNA
strand unpaired (Jenjaroenpun and Kuznetsov, 2009). A role
for R-loops in the generation of cytosolic DNA also was sup-
ported by the decreased levels of cytosolic ssDNA and dsDNA
in Rnaseh1-overexpressing cells. RNASE H1 resolves RNA:DNA
hybrids by hydrolyzing the RNA strand from the hybrids, and it
reduces RNA:DNA hybrid-induced DNA breaks, mutations,
and amplification (Helmrich et al., 2011). In contrast, overexpres-
sion of Trex1, an important ssDNA exonuclease in mammalian
cells, reduced the amounts ssDNA accumulation in the cytosol.
Cytosolic dsDNA levels were not significantly affected, indicating
that the generation of dsDNA is independent of cytosolic ssDNA.
In summary, our data suggest that R-loop-induced stalling and
collapse of replication forks contributes to the generation of
DNA in the cytosol of tumor cells.
The DDR is constitutively activated in many human cancers
as a consequence of oncogene-induced replication stress,
which can cause the stalling or collapse of replication forks
(Bartek and Lukas, 2007). Stalling of replication forks leads toseh1-IRES-Gfp. GFP+ Yac-1 cells were analyzed for the presence of cytosolic
sDNA or dsDNA staining in control-transduced (white bar) and Rnaseh1-IRES-
seh1-IRES-Gfp. GFP+ EmM1 cells were analyzed for the presence of cytosolic
of ssDNA or dsDNA staining in control-transduced (white bar) and Rnaseh1-
were analyzed and calculations were based on >100 cells in four different areas
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Figure 7. Overexpression of Rnaseh1 Re-
duces Type I IFN Expression and Rejection
of EmM1 Cells
(A) BC2 cells were transduced and treated as
described in Figure 6A. The relative transcript levels
of Ifna4 (left) and Ifnb (right) transcripts in control-
transduced (white bar), Rnaseh1-transduced (gray
bar), and Trex1-transduced (black bar) BC2 cells in
response to treatment with 10 mM Ara-C for 16 hr
were normalized toDMSO-treatedBC2 cells, which
were transduced with the respective constructs.
(B) The relative transcript levels of Ifna4 (left col-
umns) and Ifnb (right columns) in Rnaseh1-trans-
duced (gray bar) Yac-1 cells were normalized to
control-transduced (white bar) cells.
(C) IFN-b levels in the supernatant of control-
transduced (white bar) and Rnaseh1-IRES-Gfp-
transduced (gray bar) EmM1 cells were measured
by ELISA.
(D) 300 mg of IFNAR1-blocking or isotype control
antibodies were administered i.p. to C57BL/6
mice. The next day, mice were injected i.v. with
GFP+ EmM1 cells. The tumor load of GFP+ EmM1
cells in the bone marrow (left) and spleen (right)
was examined 1 day post-i.v. injection.
(E) C57BL/6 mice (n = 5) received i.p. injections of
blocking IFNAR1 antibodies (filled circle, 300 mg)
or equivalent amounts of isotype control (empty
circle) antibodies. The next day, 3 3 106 PKH26-
labeled Rnaseh1-IRES-Gfp-transduced EmM1
cells were mixed with 3 3 106 control vector-
transduced EmM1 cells. The cell mixture was in-
jected i.v. into C57BL/6 mice. Relative proportions
of Rnaseh1-IRES-Gfp-transduced to control vec-
tor-transduced EmM1 cells recovered from the
bone marrow of isotype or anti-IFNAR1 antibody-
injected mice are shown. The percentages of
Rnaseh1-transduced and control-transduced
EmM1 cells were normalized to proportions of each
population in the cell mixture cultured for 24 hr.
(F) C57BL/6 mice (n = 5) received i.p. injections of
NK cell-depleting PK136 antibodies (500 mg) or
equivalent amounts of isotype control antibodies.
The next day, mice were injected i.v. with 6 3 106
of differentially labeled Rnaseh1-IRES-Gfp-trans-
duced and control vector-transduced EmM1 cells
as described in (E). The percentages of control
vector (empty circle) or Rnaseh1-IRES-Gfp (filled
square)-transduced EmM1 cells in the spleen (left)
and bone marrow (right) were examined 1 day
post-i.v. injection. *p < 0.05, **p < 0.01, ***p <
0.001. Error bars indicate mean ± SD.the formation of extended ssDNA regions, dsDNA breaks, and
the activation of the DDR (Ciccia and Elledge, 2010). Inhibition
of the DDR-initiating kinases ATM and ATR abrogated the in-
crease of cytosolic DNA in response to genotoxic agents and
led to the disappearance of cytosolic DNA, which was
present in tumor cells. DDR-dependent HR plays a major role
in restarting stalled and collapsed forks (Allen et al., 2011).
HR-associated endonucleases and resolvases have the ability
to generate incisions in aberrant DNA structures and give rise
to DNA fragments of varying sizes that cannot be ligated (Cic-
cia and Elledge, 2010). The undamaged sister chromatid DNA470 Cell Reports 11, 460–473, April 21, 2015 ª2015 The Authorsmay serve as the template for HR-mediated repair of the
cleaved genomic fragments. However, our FISH data suggest
mechanisms that also amplify the genomic fragments in
response to DNA damage. Amplification of genomic DNA could
be the result of HR between dispersed homologous sequences,
which cause deletions but also gene duplications (Bishop and
Schiestl, 2000).
The repair of repetitive elements at stalled replication forks by
translesion synthesis also can lead to deletions or amplification
of DNA (Branzei and Foiani, 2010). Interestingly, it was recently
found that transcriptional RNA:DNA hybrids in E. coli generate
DNA ends that underlie stress-induced amplifications (Wimberly
et al., 2013). Alternatively, it is possible that cytosolic DNA is
derived from functional endogenous retrovirus present in the
mouse genome (Gasior et al., 2006), since DNA damage is
known to induce the transcription of retroelements including
transposases (Farkash and Luning Prak, 2006). However, among
the cloned DNA that could be mapped to unique genomic loca-
tions, none contained functional genes necessary for transposi-
tion. Furthermore, analysis of the surrounding genomic locations
did not reveal the presence of genes required for transposition.
Nevertheless, it is possible that the cloned retroelements co-
opt the transposases or reverse transcriptases of functional
retroelements.
The disappearance of cytosolic DNA after inhibition of the
DDR indicates the existence of mechanisms that degrade
cytosolic DNA. Time-lapse movies and confocal stainings of
A549 cells showed a partial co-localization of cytosolic DNA
with lysosome and autophagosome markers. Hence, it is
possible that a fraction of DNA in the cytosol is degraded in
lysosomes. In accordance, it was recently shown that cyto-
solic DNA can be directly taken up and degraded by autolyso-
somes (Watson et al., 2012). The lysosomal markers also were
found on some exosomes and it is therefore possible that a
subset of cytosolic DNA is excreted via exosomes (Clayton
et al., 2001).
Time-lapse microscopy indicated a dynamic interaction of
mitochondria with cytosolic DNA. A link between mitochondria
and cytosolic DNA previously was provided by the identifica-
tion of the mitochondrial antiviral signaling protein (MAVS)
and STING, two adaptors of nucleic acid sensors that are
functionally associated with mitochondria (Yanai et al.,
2009). Consistent with recognition of cytosolic DNA by DNA
sensors in tumor cells, we found that lower levels of cytosolic
DNA in Rnaseh1- or Trex1-overexpressing cells resulted in
reduced expression of type I IFNs. Cytosolic DNA might there-
fore be recognized by DNA sensors, which are functionally
associated with mitochondria and induce the expression of
type I IFNs, such as DDX41, DDX60, and IFI16 (Desmet and
Ishii, 2012).
Type I IFNs are known to have anti-tumor effects and a role
for type I IFNs in tumor immune surveillance was shown for
several different tumor types (Dunn et al., 2006). In agreement
with these observations, rejection of EmM1 cells partially de-
pended on type I IFNs. Interestingly, Rnaseh1-transduced
EmM1 cells were rejected less efficiently than control-trans-
duced EmM1 cells. Hence, the reduced type I IFN expression
of Rnaseh1-transduced EmM1 cells may contribute to the
reduced rejection. However, type I IFNs produced by co-in-
jected GFP+ control EmM1 cells may have compensated for
the reduced type I IFN expression. Hence, it is conceivable
that Rnaseh1-induced effects regulate additional factors
involved in tumor rejection. In summary, our data suggest that
DNA damage caused by replication fork stalling leads to the
presence of genome-derived DNA in the cytosol of tumor cells
and immune recognition (Figure S7). Hence, a well-defined
innate immune recognition pathway, which was characterized
in context of viral infections, may contribute to immunosurveil-
lance of cancer cells.EXPERIMENTAL PROCEDURES
Mice and Cells
C57BL/6 mice from the Centre for Animal Resources (Singapore) were bred
and housed according to the guidelines of the National University of
Singapore. BC2 and EmM1 cells are B cell lymphomas derived from late-stage
Em-Mycmice (BC2 cells were a kind gift of Dr. Corcoran, Walter and Eliza Hall
Institute of Medical Research). HCT116 cells were generously provided by
Dr. Miyagawa (Hiroshima University). All other cells were purchased from
ATCC. Cells were cultured in RPMI, McCoy, or DMEM medium (Invitrogen)
supplementedwith 10% fetal calf serum (FCS) (HyClone), 50 mM2-mercaptoe-
thanol, 200 mM asparagine, 2 mM glutamine (Sigma), and 1% pen/strep
(Invitrogen). All cells were treated with Plasmocin (InvivoGen) to exclude
potential mycoplasma contaminations.
Reagents and Constructs
Cytosine b-D-arabinofuranoside hydrochloride (Ara-C) and DMSO were pur-
chased from Sigma. Aphidicolin was obtained fromMerck. KU60019 was pur-
chased from Tocris. VE-821 was obtained from Axon Medchem.
Murine Trex1 cDNA (DNA Data Bank of Japan accession number
BC011133; Thermo Fisher Scientific) was cloned into retroviral MSCV 2.2
construct containing IRES-GFP (MSCV-GFP). The murine GIPZ lentiviral
Rnaseh1 shRNA construct (RMM4431-200321022) was purchased from GE
Healthcare. Human TREX1 (V3LHS_402257)-specific shRNAs and GIPZ
non-silencing control shRNA was purchased from Open Biosystems.
Microscopy
Cytosolic ssDNA and dsDNA stainings were performed as described previ-
ously (Lam et al., 2014). A549 cells also were stained for LC3 (PM046, MBL In-
ternational), G3BP1 (H-94), CD63 (H-193, Santa Cruz Biotechnology), LAMP2
(ab37024, Abcam), EEA1 (C45-B10, Cell Signaling Technology), or isotype-
specific antibodies followed by Alexa-488 goat anti-rabbit IgG antibody stain-
ing (Jackson ImmunoResearch Laboratories) in the presence of DAPI.
Cells were stained with 3 ml/ml PicoGreen, 3 ml/ml OliGreen, 100 nM
MitoTracker Red CMXRos, and/or 1 mg/ml Hoechst (Invitrogen) for 1 hr at
37C; 50 nM LysoTracker (Invitrogen) was added during the last 30 min of in-
cubation. Staining was examined every 9 s using anOlympus FV1000 confocal
scanning microscope equipped with a 1003 oil-immersion objective and an
ApoTome optical sectioning device (Zeiss). Pictures were analyzed using
Photoshop CS5 (Adobe), Metamorph NX (Molecular Devices), or Imaris X64
(Version 7.6.4, Bitplane). Surface rendering of 3D z stacks was done with
threshold levels set in respective experiments based on DNase I-treated and
isotype-stained slides. Intensity and co-localization calculations of cytosolic
stainings were done using Metamorph (Molecular Devices) by deducting nu-
cleus staining. Calculations were based on >100 cells and four different areas.
Cloning and Analysis of Cytosolic DNA
A detailed protocol is provided in the Supplemental Experimental Procedures.
FISH
A detailed protocol is provided in the Supplemental Experimental Procedures.
Quantitative Real-Time PCR
Quantitative real-time PCRwas performed as described previously (Lam et al.,
2014). Primers and PCR conditions are described in the Supplemental Exper-
imental Procedures.
Adoptive Transfer and In Vivo Blocking Studies
For in vivo blocking studies,mice received intraperitoneally (i.p.) 300 mgMAR1-
5A3 (IFNa/b receptor I antibodies, eBioscience), 500 mg PK136 (NK1.1 anti-
bodies, BioLegend), or equivalent amounts of mouse IgG1 k (eBioscience)
or IgG2a k (BioLegend) isotype control antibodies. The next day, Rnaseh1-
IRES-Gfp-transduced EmM1 cells were labeled with PKH26 according to the
manufacturer’s instructions (Sigma). Control vector IRES-Gfp-transduced
EmM1 cells were left unlabeled. Dead cells were removed by Ficoll gradient
centrifugation. Next, 6 3 106 of equivalently mixed Rnaseh1-IRES-Gfp and
IRES-Gfp-transduced EmM1 cells were resuspended in 200 ml PBS andCell Reports 11, 460–473, April 21, 2015 ª2015 The Authors 471
injected i.v. into C57BL/6 mice. A sample of the mixture was kept in culture.
The next day, the proportion of Rnaseh1- or control-vector-expressing
EmM1 cells in the bone marrow was analyzed by flow cytometry using
LSRFortessa (BD Biosciences) and FlowJo. 8.8.7. (Tree Star). The ratio of
Rnaseh1- to control-transduced cells was normalized to the ratio of cell
mixture cultured in vitro.
Statistical Analyses
Statistical analyses were performed using Student’s t test. Error bars
denote ± SD; *p < 0.05, **p < 0.01, ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and seven movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.03.041.
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